As told to Parliament (March 14, 2023): After Uzbekistan cough syrup deaths, Centre cautioned pharma units
All that was discussed in the House through the day
When Big Pharma has all the answers
IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …
Trial by hire
Laissez-faire in clinical research has unleashed a ruthless profit-making machine blind to notions of justice or equity. It is time to rein in …
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
Why Americans pay more for prescription drugs than anywhere else globally
The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high
India to set up 10 pharma clusters across country
The move will reduce cost of production of medicines by up to 25 per cent
Antimicrobial resistance: Here is how pharma companies can reduce antibiotic pollution in effluents
There is a high risk of antibiotic residues entering the environment from wastewater used in manufacturing pharmaceuticals
FDI in pharma: Cabinet clears KKR investments in two Indian drug firms
Union health and commerce ministries have been opposing such investment without safeguards for acquisition of domestic critical care pharma firms
US sound and fury over drug prices
The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?
Sun Pharma to buy troubled giant Ranbaxy
The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company
Profits and not improving accessibility matter to Indian drug makers
FICCI conference organised to discuss access to generic medicines focuses more on increasing exports
Antibiotic residues in wastewater may trigger antimicrobial resistance in India, China: Study
Antimicrobial resistance results in an increase in morbidity, mortality and healthcare costs for the individual, health system and country
Delhi High Court scraps ban on 344 fixed combination drugs
Health ministry banned 344 fixed combination drugs in March fearing antimicrobial resistance and other health hazards
Single nanoparticle twists pave the way for medicines on demand: Study
Understanding chirality — twists within nanoparticles — can help several industries, including pharma
Pharma’s dirty deals to stall generics
As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price
Remdisivir shows no benefits on COVID-19 patients in first clinical trial
Lancet paper contradicts Gilead results on drug which claimed improvement in patients
Finally, antiviral drug for dengue in the offing
World’s first botanical drug against dengue is in the final stage of development at the Delhi-based International Centre for Genetic …
Government stand against EU ban on Indian drugs much needed, says industry
Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
D Srinivasa Reddy takes over as Director CSIR-IICT
Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
Ranbaxy effect: Indian government defends pharma industry
Few isolated cases cannot undermine well regulated system, says commerce ministry